WallStreetZenWallStreetZen

NASDAQ: JAZZ
Jazz Pharmaceuticals PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for JAZZ

Based on 7 analysts offering 12 month price targets for Jazz Pharmaceuticals PLC.
Min Forecast
$135.00+17.91%
Avg Forecast
$191.29+67.08%
Max Forecast
$225.00+96.52%

Should I buy or sell JAZZ stock?

Based on 7 analysts offering ratings for Jazz Pharmaceuticals PLC.
Buy
Strong Buy
2 analysts 28.57%
Buy
3 analysts 42.86%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their JAZZ stock forecasts and price targets.

JAZZ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-27
lockedlocked$00.00+00.00%2023-11-09
lockedlocked$00.00+00.00%2023-11-09
lockedlocked$00.00+00.00%2023-08-22
lockedlocked$00.00+00.00%2023-08-11
Bank of America
Top 10%
91
Strong BuyMaintains$217.00+89.54%2023-08-10Find out why
Morgan Stanley
Top 36%
65
HoldReiterates$187.00+63.33%2023-07-11

1 of 1

Forecast return on equity

Is JAZZ forecast to generate an efficient return?
Company
N/A
Industry
-0.65%
Market
30.3%

Forecast return on assets

Is JAZZ forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.13%

JAZZ revenue forecast

What is JAZZ's revenue in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$3.8B+1.01%
Avg 2 year Forecast
$4.1B+8.3%
Avg 3 year Forecast
$4.4B+17%
JAZZ's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

JAZZ earnings growth forecast

How is JAZZ forecast to perform vs Biotechnology companies and vs the US market?
Company
198.64%
Industry
8.09%
Market
17.93%
JAZZ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
JAZZ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
JAZZ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

JAZZ revenue growth forecast

How is JAZZ forecast to perform vs Biotechnology companies and vs the US market?
Company
5.3%
Industry
34.07%
Market
7.56%
JAZZ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
JAZZ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

JAZZ vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
JAZZ$114.49$191.29+67.08%Buy
ROIV$9.09$16.21+78.37%Strong Buy
KRTX$185.35$261.64+41.16%Strong Buy
IONS$48.34$53.00+9.64%Buy
SRPT$82.61$145.64+76.29%Buy
View Top Biotech Stocks

Jazz Pharmaceuticals Stock Forecast FAQ

Is Jazz Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: JAZZ) stock is to Buy JAZZ stock.

Out of 7 analysts, 2 (28.57%) are recommending JAZZ as a Strong Buy, 3 (42.86%) are recommending JAZZ as a Buy, 2 (28.57%) are recommending JAZZ as a Hold, 0 (0%) are recommending JAZZ as a Sell, and 0 (0%) are recommending JAZZ as a Strong Sell.

If you're new to stock investing, here's how to buy Jazz Pharmaceuticals stock.

What is JAZZ's revenue growth forecast for 2023-2025?

(NASDAQ: JAZZ) Jazz Pharmaceuticals's forecast annual revenue growth rate of 5.3% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.56%.

Jazz Pharmaceuticals's revenue in 2023 is $3,794,392,000.On average, 10 Wall Street analysts forecast JAZZ's revenue for 2023 to be $241,288,224,065, with the lowest JAZZ revenue forecast at $238,149,003,512, and the highest JAZZ revenue forecast at $245,887,667,258. On average, 10 Wall Street analysts forecast JAZZ's revenue for 2024 to be $258,712,116,350, with the lowest JAZZ revenue forecast at $246,602,228,221, and the highest JAZZ revenue forecast at $299,605,653,276.

In 2025, JAZZ is forecast to generate $279,491,926,883 in revenue, with the lowest revenue forecast at $260,767,533,646 and the highest revenue forecast at $334,053,157,793.

What is JAZZ's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: JAZZ) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%.

What is JAZZ's Price Target?

According to 7 Wall Street analysts that have issued a 1 year JAZZ price target, the average JAZZ price target is $191.29, with the highest JAZZ stock price forecast at $225.00 and the lowest JAZZ stock price forecast at $135.00.

On average, Wall Street analysts predict that Jazz Pharmaceuticals's share price could reach $191.29 by Nov 27, 2024. The average Jazz Pharmaceuticals stock price prediction forecasts a potential upside of 67.08% from the current JAZZ share price of $114.49.

What is JAZZ's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: JAZZ) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.